C N Sang

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans
    C N Sang
    NIDR NIH Pain Research Clinic, Pain and Neurosensory Mechanisms Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, USA
    Anesthesiology 89:1060-7. 1998
  2. ncbi Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892 1258, USA
    Clin Pharmacol Ther 68:320-7. 2000
  3. ncbi Diagnostic criteria for schwannomatosis
    M MacCollin
    Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
    Neurology 64:1838-45. 2005

Detail Information

Publications3

  1. ncbi AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans
    C N Sang
    NIDR NIH Pain Research Clinic, Pain and Neurosensory Mechanisms Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, USA
    Anesthesiology 89:1060-7. 1998
    ....
  2. ncbi Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain
    I Gilron
    Pain and Neurosensory Mechanisms Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892 1258, USA
    Clin Pharmacol Ther 68:320-7. 2000
    ..Previous studies suggest that 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid (AMPA)/kainate antagonists reduce experimentally induced pain. There have been no studies of AMPA/kainate antagonists in clinical pain...
  3. ncbi Diagnostic criteria for schwannomatosis
    M MacCollin
    Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
    Neurology 64:1838-45. 2005
    ..Diagnostic criteria for schwannomatosis are needed for both clinicians and researchers, but final diagnostic certainly will await the identification of the schwannomatosis locus itself...